| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M500363200 |
| P698 | PubMed publication ID | 15722342 |
| P2093 | author name string | Elena B Pasquale | |
| Mitchell Koolpe | |||
| Monique Dail | |||
| Rosemary Burgess | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phage display | Q896217 |
| P304 | page(s) | 17301-17311 | |
| P577 | publication date | 2005-02-18 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity | |
| P478 | volume | 280 |
| Q35385982 | A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors |
| Q36967529 | Cell-cell signaling via Eph receptors and ephrins |
| Q31144876 | Combinatorial peptide libraries: mining for cell-binding peptides |
| Q41821364 | Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4 |
| Q31144324 | Discovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activity |
| Q36914295 | Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor |
| Q37625705 | Dual-Modality Micro-Positron Emission Tomography/Computed Tomography and Near-Infrared Fluorescence Imaging of EphB4 in Orthotopic Glioblastoma Xenograft Models |
| Q28251990 | Ectodomain structures of Eph receptors |
| Q34366927 | Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. |
| Q39699715 | Endothelial cells regulate cardiomyocyte development from embryonic stem cells |
| Q90250053 | Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling |
| Q34760178 | Enhancing in vitro selection techniques to assist the discovery, understanding and use of inorganic binding peptides |
| Q85010601 | Eph family receptors as therapeutic targets |
| Q35621005 | Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors |
| Q29619988 | Eph receptor signalling casts a wide net on cell behaviour |
| Q21328694 | Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis |
| Q35370195 | Eph receptors and ephrins as targets for cancer therapy |
| Q34021365 | Eph receptors and ephrins in cancer: bidirectional signalling and beyond |
| Q38257853 | Eph receptors and ephrins: therapeutic opportunities |
| Q38080387 | Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancer |
| Q37131357 | Eph receptors in breast cancer: roles in tumor promotion and tumor suppression. |
| Q27014166 | Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation |
| Q42962199 | EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. |
| Q30479634 | EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling |
| Q35676082 | EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells |
| Q49709391 | EphB4: A promising target for upper aerodigestive malignancies |
| Q38308154 | Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation |
| Q39833824 | Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor |
| Q37317736 | EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. |
| Q57265483 | EphrinB2 Signalling in Osteoblast Differentiation, Bone Formation and Endochondral Ossification |
| Q38055582 | Ephs and ephrins resurface in inflammation, immunity, and atherosclerosis |
| Q34031959 | Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis |
| Q64054503 | Essential roles of EphrinB2 in mammalian heart: from development to diseases |
| Q38272176 | Filled carbon nanotubes in biomedical imaging and drug delivery |
| Q27002511 | Henipavirus Mediated Membrane Fusion, Virus Entry and Targeted Therapeutics |
| Q30275493 | High-Throughput Approaches to the Development of Molecular Imaging Agents |
| Q27651214 | Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3 |
| Q49594373 | Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer |
| Q36232264 | Investigation of the interactions between the EphB2 receptor and SNEW peptide variants |
| Q31040344 | Involvement of EphB/Ephrin-B Signaling in Axonal Survival in Mouse Experimental Glaucoma |
| Q42380690 | Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass |
| Q42230107 | Overexpression of the B-type Eph and ephrin genes correlates with progression and pain in human pancreatic cancer |
| Q28741459 | PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity |
| Q38106027 | PET Imaging of Colorectal and Breast Cancer by Targeting EphB4 Receptor with64Cu-Labeled hAb47 and hAb131 Antibodies |
| Q37633690 | Paradoxes of the EphB1 receptor in malignant brain tumors. |
| Q33800879 | Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors |
| Q35032526 | Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts |
| Q33532734 | Phage display in molecular imaging and diagnosis of cancer |
| Q33530848 | Potential of phage-displayed peptide library technology to identify functional targeting peptides |
| Q91756320 | Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients |
| Q39598153 | Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells |
| Q38618616 | Rational, computer-enabled peptide drug design: principles, methods, applications and future directions. |
| Q90613304 | Recapitulating complex biological signaling environments using a multiplexed, DNA-patterning approach |
| Q38219833 | Receptor tyrosine kinases in osteosarcoma: not just the usual suspects |
| Q46792289 | Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours |
| Q39586973 | Reelin induces EphB activation |
| Q33333780 | Selection of phage-displayed peptides that bind to a particular ligand-bound antibody |
| Q30830186 | Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow. |
| Q41875227 | Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors |
| Q24298026 | Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity |
| Q27653652 | Structure of the ligand-binding domain of the EphB2 receptor at 2 Å resolution |
| Q39672762 | Structure-activity relationship analysis of peptides targeting the EphA2 receptor |
| Q34292760 | TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting |
| Q37951723 | Targeting Eph receptors with peptides and small molecules: Progress and challenges |
| Q92712299 | Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions |
| Q26799461 | Targeting the Eph System with Peptides and Peptide Conjugates |
| Q40252238 | The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway |
| Q38041858 | The roles and therapeutic potentials of Ephs and ephrins in lung cancer. |
| Q33677805 | The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis |
| Q27648574 | Three-dimensional Structure of the EphB2 Receptor in Complex with an Antagonistic Peptide Reveals a Novel Mode of Inhibition |
| Q36025723 | Tumor-targeting peptides from combinatorial libraries |
Search more.